757
Participants
Start Date
July 21, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
May 17, 2017
dihydroartemisinin-piperaquine
Participating infants with uncomplicated malaria will be treated with a three day course (1 dose/day) of DHP (containing 40 mg dihydroartemisinin and 320 mg piperaquine) administered as a total dose over three days of 6mg/kg of dihydroartemisinin and 57 mg/kg of piperaquine.
Timika Research Facility, Timika
Timika Research Facility, Indonesia
UNKNOWN
Eijkman Institute for Molecular Biology
OTHER
Menzies School of Health Research
OTHER
Gadjah Mada University
OTHER